This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2025
12-15 May 2025Congress Center Hamburg, Germany

Terri Gaskell
CTO at Rinri Therapeutics


CTO at Rinri Therapeutics, developing novel regenerative cell therapies in the field of hearing loss. Terri has over 20 years of life sciences R&D experience in both academic and industry roles with a focus on the development and translation of cell- and gene-based therapies. Terri joined Rinri from the Cell and Gene Therapy Catapult where she worked for over seven years on the translation of a broad range of candidate therapies, including stem cell derived, alongside underpinning technologies and infrastructure. Her role at CGT Catapult also included advising academics and small companies on the development of advanced therapies. Prior to this, Terri held senior roles in industry focussed on the development of processes for the expansion and differentiation of pluripotent stem cells for therapeutic use and drug discovery. Terri received her BSc. (Hons) in Biochemistry from the University of Dundee and holds a PhD in Cell and Molecular Biology from the University of Edinburgh.

Agenda Sessions

  • Chair’s Welcome Remarks: Cell and Gene Therapy Manufacturing

  • Chairperson Remarks: Cell and Gene Therapy Manufacturing